LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,993,059 | -22.8% | 33,262 | -7.2% | 0.00% | 0.0% |
| Q2 2023 | $2,582,982 | -12.0% | 35,825 | -10.2% | 0.00% | -50.0% |
| Q1 2023 | $2,935,044 | +110698.2% | 39,900 | +0.6% | 0.00% | 0.0% |
| Q4 2022 | $2,649 | -99.9% | 39,658 | +40.2% | 0.00% | 0.0% |
| Q3 2022 | $2,436,000 | +267.4% | 28,290 | +280.7% | 0.00% | – |
| Q2 2022 | $663,000 | -21.1% | 7,431 | -0.5% | 0.00% | – |
| Q1 2022 | $840,000 | -26.8% | 7,471 | +0.5% | 0.00% | -100.0% |
| Q4 2021 | $1,148,000 | +10.8% | 7,431 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,036,000 | +26.5% | 7,434 | +19.1% | 0.00% | 0.0% |
| Q2 2021 | $819,000 | -10.7% | 6,243 | +3.7% | 0.00% | 0.0% |
| Q1 2021 | $917,000 | -86.3% | 6,018 | -91.1% | 0.00% | -80.0% |
| Q4 2020 | $6,708,000 | +0.5% | 67,447 | -3.6% | 0.01% | -16.7% |
| Q3 2020 | $6,672,000 | -19.9% | 69,995 | -6.0% | 0.01% | -25.0% |
| Q2 2020 | $8,326,000 | +46.1% | 74,438 | -5.0% | 0.01% | +14.3% |
| Q1 2020 | $5,697,000 | -37.2% | 78,346 | -9.9% | 0.01% | -22.2% |
| Q4 2019 | $9,066,000 | -7.3% | 86,927 | -11.5% | 0.01% | -18.2% |
| Q3 2019 | $9,775,000 | +0.2% | 98,198 | +14.9% | 0.01% | 0.0% |
| Q2 2019 | $9,754,000 | -45.8% | 85,448 | -38.0% | 0.01% | 0.0% |
| Q1 2019 | $17,990,000 | +100.6% | 137,861 | +108.5% | 0.01% | -8.3% |
| Q4 2018 | $8,970,000 | -23.3% | 66,105 | +55.1% | 0.01% | -14.3% |
| Q3 2018 | $11,698,000 | +26.2% | 42,619 | -4.7% | 0.01% | +16.7% |
| Q2 2018 | $9,268,000 | +19.6% | 44,734 | -4.7% | 0.01% | +20.0% |
| Q1 2018 | $7,749,000 | +2.8% | 46,918 | -14.8% | 0.01% | 0.0% |
| Q4 2017 | $7,540,000 | -1.7% | 55,061 | -2.3% | 0.01% | -9.1% |
| Q3 2017 | $7,673,000 | +4.8% | 56,355 | -6.5% | 0.01% | 0.0% |
| Q2 2017 | $7,320,000 | +14.5% | 60,300 | -0.1% | 0.01% | +10.0% |
| Q1 2017 | $6,392,000 | -3.9% | 60,390 | -7.8% | 0.01% | -16.7% |
| Q4 2016 | $6,654,000 | -9.9% | 65,490 | -9.5% | 0.01% | -7.7% |
| Q3 2016 | $7,388,000 | -19.5% | 72,390 | 0.0% | 0.01% | -23.5% |
| Q2 2016 | $9,176,000 | +4.3% | 72,390 | +2.6% | 0.02% | 0.0% |
| Q1 2016 | $8,794,000 | +14.9% | 70,583 | 0.0% | 0.02% | +13.3% |
| Q4 2015 | $7,653,000 | +26.4% | 70,583 | -0.1% | 0.02% | +15.4% |
| Q3 2015 | $6,054,000 | -25.6% | 70,683 | -12.3% | 0.01% | -18.8% |
| Q2 2015 | $8,133,000 | +28.8% | 80,608 | -1.6% | 0.02% | +23.1% |
| Q1 2015 | $6,316,000 | +44.9% | 81,908 | 0.0% | 0.01% | +44.4% |
| Q4 2014 | $4,358,000 | +163.0% | 81,908 | +132.3% | 0.01% | +125.0% |
| Q3 2014 | $1,657,000 | -27.9% | 35,258 | -4.5% | 0.00% | -20.0% |
| Q2 2014 | $2,299,000 | – | 36,908 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |